Sign Up
Physician Login
dermtech 2_0 logo

The DermTech Melanoma Test has $0 out-of-pocket costs for Medicare.

Learn More

Meet the DermTech Melanoma Test®

tooltip text
The negative predictive value is the probability a person with a negative test result does not have the disease.
The DermTech Melanoma Test has helped patients over 300,000 times.

Trusted by over 3,000 dermatology clinicians.

Confidently rule out melanoma with the 99% NPV of the DermTech Melanoma Test1
tooltip text
The negative predictive value is the probability a person with a negative test result does not have the disease.
The DermTech Melanoma Test has helped patients over 300,000 times.
Trusted by over 3,000 dermatology clinicians.

The DermTech Melanoma Test® is a non-invasive genomic test utilizing DermTech Smart Stickers® to assess equivocal melanocytic lesions meeting one or more of the ABCDE criteria. It detects genomic markers associated with melanoma to distinguish benign from higher risk lesions.1

The DermTech Melanoma Test has a 99% negative predictive value (NPV), meaning that with a negative test result, there is a 99% probability that the lesion is not melanoma.

Learn About the Test

Harnessing Precision Genomics in Dermatology

Certain genomic abnormalities precede morphologic changes.2,3,4

conceptual model
View Full Image
Q

Genomic changes drive disease progression. The absence of gene expression by optimized melanoma associated genomic markers LINC00518 and PRAME can give a provider confidence in ruling out melanoma. The DermTech Melanoma Test’s has a 99% negative predictive value, meaning there is a 99% probability that a negative lesion is not melanoma.

The innovative DermTech 2.0 Lab is CLIA certified, JCO accredited, and licensed by the New York State Department of Health.

The Joint Commission
CLIA

Adopt the DermTech Melanoma Test into your practice today.

Let's Get Started

References:

1. Gerami P, et al. J Am Acad Dermatol. 2017;76(1):114-120. 2. Malvehy J, et al. Br J Dermatol. 2014;171(5):1099-1107. 3. Skelsey M, et al. SKIN J Cutan Med. 2021;5(5):512-523. 4. Shain AH, et al. Cancer Cell. 2018;34(1):45-55.e4.